Skip to main content
. 2019 Nov 8;10(12):2089–2101. doi: 10.1039/c9md00358d

Table 4. Cellular viabilities after treatment with the selected compounds for 24 h using MTT assay (IC50) in Vero, HepG2, and C6 cell lines.

IC50 ± SEM (μM)
Compound Vero HepG2 C6
8b >250.0 >250.0 >250.0
9a >250.0 >250.0 >250.0
7b 115.4 ± 4.2 116.4 ± 0.1 >250.0
Tacrine 168.9 ± 14.0 114.9 + 17.9 450.7 ± 4.2